A major component to successfully establish radioligand therapy
Tackling the Last Mile: A major component to successfully establish [...]
Estimate the anticipated benefit from Lutetium-177-DOTATATE
External Validation of a Clinical Score for Patients With Neuroendocrine [...]
Drugmakers push into radio pharmaceuticals
Dolgin, E. Drugmakers go nuclear, continuing push into radiopharmaceuticals. Nat Biotechnol 39, 647–649 [...]
Doctor, What is Neuroendocrine Cancer?
Waiting for a download is frustrating. Imagine waiting 5+ years [...]
How PRRT can Improve Care for Neuroendocrine Tumor Patients
Learn more about how Peptide Receptor Radionuclide Therapy (PRRT) can [...]
NET Patient Testimonial, how PRRT saved Tom’s life
Tom is a composer, pianist, audio producer and neuroendocrine tumor patient. [...]
EANM FOCUS MEETING – Theranostics for NET’s
Event: EANM FOCUS 3 - Molecular Imaging and Theranostics in [...]